Schludin Biopharmaceutical Company is a core business unit of Schludin Pet Care Industry Group, established in 2017, dedicated to providing specialized and precise medical drugs and nutritional health solutions for pet animals. As a pioneer in the field of animal protection for exotic pets in China, the company is committed to the mission of "scientifically safeguarding the diversity of life" and has built a full industry chain ecology covering case research, product development, production and sales, and medical services. Its service targets include dozens of characteristic exotic animals such as birds, reptiles, aquariums, racing pigeons, and horses. It is one of the few comprehensive modern exotic pet protection enterprises in the industry.